Andrew brings over 15 years of international executive experience in marketing, commercial excellence, and business strategy, leading large teams in top pharmaceutical and medical device companies such as Novartis, Terumo and Penumbra Inc. He is a proud graduate of the IGNITE Program at Stanford GSB and has also studied at several other prestigious international business schools.

Previously the engineering director for the world's first wireless wearable ultrasound, Kyle additionally operated as the entire electro-mechanical and manufacturing engineering arm at Flosonics Medical in addition to designing and manufacturing a first of it's kind ultrasound transducer. With a background in mechanical engineering and mechatronics , He specializes in electro-mechanical product engineering and biosensor design.
Developing over 50+ mass manufactured products across fields in Medical science, industrial equipment, consumer electronics, agriculture, mining and wind/solar energy.
Kyle is named on 15+ patents, Received gold awards in International Design - Grands Prix Du Design and Best Medical Life Science product - International Design Awards - IDA

Marie Muller is an Associate Professor in Mechanical and Aerospace Engineering at North Carolina State University. She received her B.S. in Physics from the Pierre et Marie Curie University in Paris, France in 2002, and her Ph.D in Physical Acoustics from the University of Paris, France in 2006. After a postdoctorate at the Erasmus Medical Center in Rotterdam, the Netherlands, she returned to Paris, as an Assistant Professor with the Institut Langevin. In 2014, she moved to North Carolina and joined the Mechanical and Aerospace Engineering department at NCSU. She is also an associate Faculty with the Joint Department of Biomedical Engineering at UNC and NCSU. Dr. Muller’s work has been recognized with several awards, including the Galien Medstartup Award in 2020, in collaboration with E-scopics, the ICU Early Career Award, the Young Investigator Award from the French Society of Acoustics, the PhD thesis award from the French Society of Biological and Medical Engineering and IEEE France Section, the Prize for a Young Parisian female researcher from the City of Paris, and the Stephens award at the International Congress of Ultrasonics. She is a member of IEEE - UFFC, the Acoustical Society of America, and of the American Institute of Ultrasound in Medicine. She is also a founding member and member of the board of the International Bone Ultrasound Society.

Jean holds the position of the Professor of Surgery University of South Florida, Chief for Division of Vascular Surgery, Medical Director for Vascular Center of Excellence for Tampa General Hospital Heart and Vascular Institute, Adjunct Professor of Surgery Rice University for the Institute of Biosciences and Bioengineering and institute of Mechanical Engineering

Alick Liu has dedicated over two decades to engineering leadership in both major tech entities and nimble startups. With a breadth of experience that encompasses the US, Europe, and Asia, he has consistently showcased his prowess in cross-cultural leadership. Alick’s standout contributions have been in the realm of product development, where he has been pivotal in both conceptualizing and scaling a wide array of advanced tech products. Anchored in deep engineering know-how and an innovative spirit, Alick continues to be a driving force in the tech world, translating vision into tangible successes.

Dr. Mark A. Adelman was the Endowed Chair and Frank J. Veith Professor (Tenured) and Chief of the Division of Vascular and Endovascular Surgery at NYU Langone Medical Center until 2018. After receiving his undergraduate degree in Biology from the University of Virginia, he completed his medical school, residency, and fellowship training at New York University School of Medicine. Dr. Adelman joined the faculty in 1991, was named Chief of the Division of Vascular Surgery in 2006 and assumed the role of Vice Chairman of Strategy and Business Development for the Department of Surgery in 2013. He served as President of the School of Medicine Faculty for four years and Senator to the NYU Faculty Senators Council where he was the medical school representative to the President’s Advisory Council on Academic Priorities.

Dr. Adelman is well known nationally and internationally for his academic accomplishments and is a leader in many prestigious surgical societies including the Vascular Surgical Society of Great Britain and Ireland, and the American Surgical Association. He has published nearly 150 peer-reviewed manuscripts, is well recognized by the media for his contributions in vascular disease and has been an innovator in the endovascular treatment of venous, carotid, and aortic diseases. He holds three U.S. and international patents for surgical instrumentation. Dr. Adelman has been an investigator in more than 30 clinical trials and has been involved with and chaired several Data Safety Monitoring Boards and Clinical Events Committees. He has been named to New York Magazine’s list of Top Doctors and to Castle and Connolly’s America’s Top Doctors for 20 consecutive years. After retiring from clinical practice, he served as CMO at a large multinational CRO, and is now co-chairman of two large vascular symposia serving an international audience. His clinical interests include peripheral arterial disease, venous pathology, endovascular treatment of aortic aneurysms, and diseases of the carotid artery. He is currently the Chief Medical Officer of Hoth Intelligence and on the medical advisory board of IntelVasc.

Dr. Frank J. Veith is an esteemed American vascular surgeon who currently serves as a Professor of Surgery at both the New York University Medical Center and the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is recognized as a pioneer in lung transplantation and limb-salvage surgery. Notably, he was the first vascular surgeon in the United States to perform minimally invasive aortic aneurysm surgery (stent-graft procedure) in collaboration with Drs. Michael L. Marin, Juan C. Parodi, and Claudio J. Schonholz.

Dr. Veith’s illustrious career is marked by his significant contributions to medical literature, having authored or co-authored more than 1,000 original articles and chapters in medical journals, particularly on limb-salvage surgery and the field of endovascular grafting for traumatic, aneurysmal, and occlusive arterial disease. He has held prestigious positions such as the chairman of the American Board of Vascular Surgery, president of the regional Eastern and New York Vascular Societies, and served as the 50th president of the Society for Vascular Surgery.

Todd E. Rasmussen, M.D., is a vascular surgeon with a special interest in vascular reconstruction for traumatic injuries, combat casualty care, vascular trauma, and carotid artery disease. He approaches care with a patient-centered and personalized focus. Dr. Rasmussen holds the position of professor and vice-chair for Education in the Department of Surgery at Mayo Clinic in Rochester, Minnesota. His clinical expertise encompasses vascular and endovascular surgery, aneurysm surgery (including aortic aneurysm repair and endovascular aneurysm repair and reconstruction), thoracoabdominal aneurysm surgery, and thoracic outlet decompression. Additionally, he performs angiograms, angioplasties, carotid angiograms, and carotid angioplasty and stenting.

Dr. Rasmussen earned his medical degree from the Mayo Clinic College of Medicine in Rochester, MN. He completed his surgical residency at Wilford Hall Air Force Medical Center at Lackland Air Force Base in Texas and his fellowship in peripheral vascular surgery at the Mayo Clinic College of Medicine.

Before joining Mayo Clinic, Dr. Rasmussen had a distinguished twenty-year career as an Air Force surgeon. During his military service, he completed deployments to Iraq, Afghanistan, and other global locations. Dr. Rasmussen also led significant translational research programs for the Department of Defense, resulting in over three hundred publications, an h-index exceeding fifty-five, and more than ten thousand citations. Notably, he co-invented the REBOA catheter, a life-saving medical device. His contributions were recognized with the Defense Superior Service Medal upon his retirement as a Colonel in 2021

James Pray is a co-founder and former President, International of Penumbra. He held this position from the company’s foundation in 2005 until his retirement in 2022. Before co-founding Penumbra, Mr. Pray enjoyed a successful career in the medical device industry, with special focus on the neurovascular space. He held executive positions at leading medical device companies such as Boston Scientific and SCIMED Life Systems.

Currently, Mr. Pray is a notorious investor and influential figure in the medical device industry in the United States and international markets.

Mr. Pray earned both his B.S. and M.S. degrees from the University of Minnesota.

David Uffer is a seasoned executive with over 30 years of experience in the MedTech industry, specializing in advancing medical devices, diagnostics, and digital health. His career includes leadership roles in strategy consulting, transaction advisory, venture investing, and health economics and outcomes research (HEOR), as well as market access and clinical affairs. Currently, David serves as Managing Director at Trinity Life Sciences, where he leads the MedTech division, offering strategic guidance to top healthcare organizations globally.

David’s previous roles include heading the MedTech portfolio at General Inception, serving as Senior Partner at Alira Health, and managing business development for Medtronic’s (legacy Covidien) $5 billion division across 22 business lines. He has also directed corporate development at Hologic, focusing on gynecologic surgery, breast health, and molecular diagnostics, and contributed to Boston Scientific’s strategy in vascular surgery, interventional medicine, and oncology. David’s expertise is further underscored by his leadership at Integra Lifesciences and Abbott Labs. A graduate of Clark University with an MBA from Thunderbird School of Global Management, David has consistently driven innovation and commercialization in healthcare throughout his distinguished career.

Dr. Jay Matthews is a distinguished Interventional Cardiologist with over 25 years of experience, primarily practicing at Manatee Memorial Hospital.

 

In addition to his clinical practice, Dr. Matthews is actively engaged in cardiovascular research, with numerous publications in prestigious journals such as Cardiovascular Interventions from the American Heart Association (AHA) and the Journal of the American College of Cardiology (JACC). His research contributions have significantly advanced the understanding and treatment of cardiovascular diseases.

 

Dr. Matthews also plays an active role in the Planning Committee for the VEINS Meeting (VEINS/VIVA) and serves as Chairman at NCVH Tampa Bay. Through his leadership, he continues to drive innovation and excellence in cardiovascular care.

Prof. Dr. Sillesen is a distinguished professor of vascular surgery and global KOL that has cultivated a remarkable career serving over two decades as a specialist and ultimately, as chief of the vascular surgery department at Rigshospitalet in Copenhagen. Dr. Sillesen has held significant roles such as president at the European Society of Vascular Surgery, advisor for several national and international healthcare bodies, and within the clinical medicine department of a major philanthropic foundationThroughout his extensive career, Dr. Sillesen has been driving innovation in patient care and expanding the field’s knowledge base through rigorous research. With over 260 articles published in high-impact journals and a record of delivering more than 250 international lectures across 35 countries, his influence resonates globally. Presently, Dr. Sillesen contributes to innovation by serving in executive and advisory positions in leading startups within his medical space.